Mike Bassett from MedPage Today - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism		Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients - 7 days ago Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer - 8 days ago Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL - 12 days ago Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma - 12 days ago Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP - 14 days ago Some Older Adults Think Stopping CRC Screening at Age 75 Is 'Unacceptable' - 18 days ago New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show - 23 days ago FDA Approves Zanidatamab for Biliary Tract Cancer - 29 days ago Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - 30 days ago New MELD Model Improves Access to Liver Transplant for Women - about 1 month ago Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplant - about 1 month ago Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests - about 1 month ago FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - about 2 months ago What Is the Optimal Reliever Therapy for Difficult-to-Control Asthma? - about 2 months ago Dupilumab Proves Effective in Chronic Spontaneous Urticaria - about 2 months ago Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Disease - about 2 months ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 3 months ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 3 months ago No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer - 3 months ago Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets - 3 months ago No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma - 3 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 3 months ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 4 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 4 months ago Trial Questions Role of Dual Immunotherapy in First-Line NSCLC - 4 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 4 months ago Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer - 4 months ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - 5 months ago FDA Greenlights First Engineered Cell Therapy for a Solid Tumor - 5 months ago EHR 'Nudge' Cut Low-Value Surgery Rates in Older Breast Cancer Patients - 5 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 5 months ago Mediterranean Diet Tied to Lower Mortality Risk in Cancer Survivors - 6 months ago Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT - 6 months ago Most Women Can Have Successful Pregnancies After Breast Cancer Treatment - 7 months ago Blood Test for Colon Cancer Screening Secures FDA Panel's Blessing - 7 months ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 8 months ago Journey Into Virtual Reality Eases Cancer Pain - 8 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 8 months ago Novel PARP1 Inhibitor Shows Promise in Breast Cancer - 9 months ago Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? - 9 months ago Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials - 9 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 9 months ago More Bird Flu Spread; FDA to Allow Gay Men to Donate Sperm; 'Oatzempic' Trend - 9 months ago Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer - 9 months ago Evidence Strengthens for De-Escalating Axillary Surgery in Breast Cancer - 9 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 9 months ago Liquid Biopsy for CRC Screening May Not Be Ready for Prime Time - 9 months ago Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer - 9 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 9 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 9 months ago